NCT07053813
Applying Population Management Best Practices to Preventative Genomic Medicine Trial
Enrolling by Invitation
NAAges 18–75InterventionalPreventionUniversity of WashingtonInvestigator-initiated
~900 participants
Updated 2026-02-27 on ClinicalTrials.gov
What's tested:Web resourcesPersonalized outreach
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion time covered
Measured over 12 months following randomization
Conditions
Where it's being run
2 sites across 2 statesColorado1
Oregon1
Study leadership
- Sarah Knerr, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of Washington
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Clinically actionable variant in at least one high penetrance cancer-related gene
Age- and sex- eligible for guideline indicated risk management
Remains eligible for risk management, given personal cancer and surgical history
Exclusion
Previously opted out of research
Previously opted out of genetic research
On hospice or palliative care
Has advanced dementia or severe cognitive impairment
What this trial measures
- Proportion time covered12 months following randomization
Proportion time covered by recommended cancer screening